A pharmacovigilance study on probiotic preparations based on the FDA Adverse Event Reporting System from 2005 to 2023
一项基于FDA不良事件报告系统2005年至2023年益生菌制剂药物警戒研究
期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.8
doi:10.3389/fcimb.2025.1455735
Wang, Yitong; Tan, Weifu; Li, Xuyang; Yang, Guangli; Wang, Yunxiao; Liao, Jing; Lu, Aner; Zhang, Guoqing; Chen, Kuidai; Yang, Liling; Li, Wei
